Cornerstones Health Presents:

Best of DDW in IBD 2021
Live Interactive Webinars

An Update in Diagnosis, Prognosis, and Management of IBD

Dear Colleague,

Cornerstones Best of Digestive Disease Week in Inflammatory Bowel Disease 2021 Webinars are Coming Soon!

Cornerstones’ 12th Annual Best of DDW in IBD 2021 webinars will provide world-class education on the most important scientific and clinical advances from Digestive Disease Week 2021. Developed by our team of 40 international inflammatory bowel disease experts during the virtual DDW congress, these live interactive webinars will be facilitated by nationally known faculty educators actively involved in the management and treatment of IBD.

The Best of DDW in IBD webinars will provide a condensed and synthesized update on the state-of-the-art research and practical clinical information presented during DDW. The goal is to provide you with the most pertinent data, allowing you and your IBD team to implement new understanding into your practice to improve patient care.

Register today to secure your place in one of our Best of DDDW in IBD Webinars.

Sincerely,

Marla C. Dubinsky, MD	David T. Rubin, MD
Co-Founders, Cornerstones Health

Tuesday • June 22, 2021

8:00pm - 9:30pm ET (5:00pm - 6:30pm PT)

Dermot McGovern, MD, PhD

Cedars-Sinai Medical Center

Thomas A. Ullman, MD

Montefiore Health System

Wednesday • June 23, 2021

8:00pm - 9:30pm ET (5:00pm - 6:30pm PT)

David G. Binion, MD

University of Pittsburgh School of Medicine

Corey Siegel, MD, MS

Dartmouth-Hitchcock Medical Center

Thursday• June 24, 2021

8:00pm - 9:30pm ET (5:00pm - 6:30pm PT)

Marla Dubinsky, MD

Icahn School of Medicine, Mount Sinai Hospital

Edward Loftus Jr., MD

Mayo Clinic College of Medicine

Tuesday • June 29, 2021

8:00pm - 9:30pm ET (5:00pm - 6:30pm PT)

David T. Rubin, MD

University of Chicago Medicine

Alexandra Masching, MSN, APN, FNP-BC

University of Chicago Medicine

Thursday• July 8, 2021

6:00pm - 7:30pm ET (3:00pm - 4:30pm PT)

Uma Mahadevan-Velayos, MD

University of California at San Francisco

Miguel Regueiro, MD

Cleveland Clinic

Learning Objectives

After successful completion of this CME/CE activity, participating members of the IBD care team are expected to be better able to:

• Incorporate advances in therapeutic options and understanding of biologics, small molecules, biosimilars, and non-medical therapies for the treatment of Crohn’s disease & ulcerative colitis
• Consider the implications for short-term outcomes in IBD based on clinical presentation and treatment strategy
• Incorporate quality measures to improve patient health and quality-of-life outcomes
• Collaborate with other members of the care team to individualize management for people living with IBD

Target Audience

This program is specifically designed for gastroenterologists, NPs, PAs, and fellows involved in the management of patients with IBD.

Accreditation and Credit Designation

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Cornerstones Health. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

American Academy of CME, Inc., designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn ABIM MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Your points will be automatically submitted to the ABIM on your behalf; please allow 4 weeks for your points to display on the ABIM website.

NPs

American Academy of CME, Inc., designates this educational activity for 1.5 ANCC contact hours (1.15 pharmacotherapeutic contact hours).

California: Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.

PAs

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits.

PAs should only claim credit commensurate with the extent of their participation.

Support

Support for this activity has been made possible through educational grants from: AbbVie, Bristol Myers Squibb, Pfizer Inc., and Takeda Pharmaceuticals USA

Digestive Disease Week®

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), the meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org.